Predicting response to lithium in bipolar disorder: A critical review of pharmacogenetic studies

Journal of Mental Health

Volumn 19, Issue 2, 2010, Pages 142-156

  Smith, Daniel J ^a   Evans, Rhiannon ^a   Craddock, Nick ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bipolar disorder; Lithium; Mood disorders; Pharmacogenetics

Indexed keywords

BENZODIAZEPINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; INOSITOL POLYPHOSPHATE 1 PHOSPHATASE; LITHIUM CHLORIDE; MITOCHONDRIAL DNA; PHOSPHATASE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

BIPOLAR DISORDER; CLINICAL TRIAL; DATA BASE; DNA POLYMORPHISM; DRUG RESPONSE; ELECTRONIC MEDICAL RECORD; GENETIC VARIABILITY; GENOTYPE; HUMAN; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; PHARMACOGENETICS; PREDICTOR VARIABLE; REVIEW; TREATMENT DURATION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA, MITOCHONDRIAL; HUMANS; LITHIUM CARBONATE; PHARMACOGENETICS; PHOSPHORIC MONOESTER HYDROLASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TREATMENT OUTCOME;

EID: 77950821299     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.3109/09638230903469103     Document Type: Review

References (29)

1. Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005). Longterm response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-[beta] -50 T/C SNP. Neuroscience Letters, 376(1), 51-55.
2. Blanco, C., Laje, G., Olfson, M.,Marcus, S.C., & Pincus, H.A. (2002). Trends in the treatment of bipolar disorder by outpatient psychiatrists. American Journal of Psychiatry, 159(6), 1005-1010. (Pubitemid 34586947)
3. Craddock, N., O'Donovan, M., & Owen, M. (2008). Genome-wide association studies in psychiatry: Lessons from early studies of non-psychiatric and psychiatric phenotypes. Molecular Psychiatry, 13(7), 649-653.
4. Goodwin, F.K., & Jamison, K.R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression. New York: Oxford University Press.
5. Green, E.K., Raybould, R., Macgregor, S., Hyde, S., Young, A.H., O'Donovan, M.C., Owen, M.J., Kirov, G., Jones, L., Jones, I., & Craddock, N. (2006). Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: Case-control study of over 3000 individuals from the UK. British Journal of Psychiatry, 188(1), 21-25.
6. Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K.P. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66, 2621-2624.
7. Kato, T., Kunugi, H., Nanko, S., & Kato, N. (2001). Mitochondrial DNA polymorphisms in bipolar disorder. Journal of Affective Disorders, 62, 151-164. (Pubitemid 32167082)
8. Kleindienst, N., Engel, R.R., & Greil, W. (2005a). Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disorders, 7(5), 404-417. (Pubitemid 41419407)
9. Kleindienst, N., Engel, R.R., & Greil, W. (2005b). Psychosocial and demographic factors associated with response to prophylactic lithium. A systematic review for bipolar disorders. Psychological Medicine, 35, 1685-1694. (Pubitemid 41672347)
10. Lesch, K.P., & Heils, A. (2000). Serotonergic gene transcriptional control regions: Target for antidepressant drug development. International Journal of Neuropsychopharmacology, 3, 67-79.
11. Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Kunugi, H., & Koyama, T. (2006). A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. Journal of Neuropsychopharmacology, 9, 83-88.
12. Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., Kunugi, H., & Koyama, T. (2006). Lithium response and Val66Met polymorphism of the brainderived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatric Genetics, 16(2), 49-50.
13. Michelon, L., Meira-Lima, I., Cordeiro, Q., Miguita, K., Breen, G., Collier, D., & Vallada, H. (2006). Association study of the INPP1, 5HTT, BDNF, AP-2[beta] and GSK-3[beta] GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neuroscience Letters, 403(3), 288-293.
14. NICE (2006). Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. www.nice.org.uk/CG038
15. Rybakowski, J.K., Suwalska, A., Czerski, P.M., Dmitrzak-Weglarz, M., Leszczynskia-Rodziewicz, A., & Hauser, J. (2005a). Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacological Reports, 57, 124-127.
16. Rybakowski, J.K., Suwalska, A., Skibinska, M., Dmitrzak-Weglarz, M., Leszczynska-Rodziewicz, A., & Hauser, J. (2007). Response to lithium prophylaxis: Interaction between serotonin transporter and BDNF genes. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 144B, 820-823.
17. Rybakowski, J.K., Suwalska, A., Skibinska, M., Szczepankiewicz, A., Leszczynska-Rodziewicz, A., Permoda, A., Czerski, P.M., & Hauser, J. (2005b). Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry, 38(4), 166-170. (Pubitemid 41059223)
18. Serretti, A., Lorenzi, C., Lilli, R., Mandelli, L., Pirovano, A., & Smeraldi, E. (2002). Pharmacogenetics of lithium prophylaxis in mood disorders: Analysis of COMT, MAO-A, and Gß3 variants. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 144, 370-379.
19. Serretti, A., Lorenzi, C., Lilli, R., & Smeraldi, E. (2000). Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. Journal of Psychiatric Research, 34(2), 89-98. (Pubitemid 30176115)
20. Serretti, A., Lilli, R., Lorenzi, C., Franchini, L., Di Bella, D., Catalano, M., & Smeraldi, E. (1999a). Dopamine receptor D2 and D4 genes, GABAA alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Psychiatry Research, 87, 7-19.
21. Serretti, A., Lilli, R., Lorenzi, C., Franchini, L., & Smeraldi, E. (1998). Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders. International Journal of Neuropsychopharmacology, 1, 125-129.
22. Serretti, A., Lilli, R., Lorenzi, C., Gasperini, M., & Smeraldi, E. (1999b). Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. Journal of Psychiatric Research, 33, 371-377.
23. Serretti, A., Lilli, R., Mandelli, L., Lorenzi, C., & Smeraldi, E. (2001). Serotonin transporter gene associated with lithium prophylaxis in mood disorders. The Pharmacogenomics Journal, 1, 71-77.
24. Sklar, P., Gabriel, S.B., McInnes, M.G., Bennett, P., Lim, Y.M., Tsan, G., Scaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., Depaulo, J.R., & Lander, E.S. (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF as a potential risk locus. Molecular Psychiatry, 7, 579-593.
25. Smith, L.A., Cornelius, V., Warnock, A., Bell, A., & Young, A.H. (2007). Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: A systematic review of randomized controlled trials. Bipolar Disorders, 9(4), 394-412.
26. Steen, V.M., Løvlie, R., Osher, Y., Belmaker, R.H., Berle, J.Ø., & Gulbrandsen, A.K. (1998). The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics, 8, 259-268.
27. Washizuka, S., Ikeda, A., Kato, N., & Kato, T. (2003). Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. International Journal of Neuropsychopharmacology, 6, 421-424.
28. WTCCC (Wellcome Trust Case Control Consortium) (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661-678.
29. Young, A.H., & Hammond, J.M. (2007). Lithium in mood disorders: Increasing evidence base, declining use? British Journal of Psychiatry, 191(6), 474-476.